GRP78/HSPA5 Antibody (1H11-1H7) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-12888H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat, Bovine, Fungi, Hamster, Monkey, Rabbit, Xenopus
Applications
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
HRP
Antibody Source
Monoclonal Mouse IgG2B Clone # 1H11-1H7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
His-tagged human GRP78
Localization
Endoplasmic Reticulum , Endoplasmic Reticulum Lumen , Melanosome
Specificity
Detects a protein with a mass of approx. 78kDa corresponding to GRP78
Marker
ER Stress Marker
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for GRP78/HSPA5 Antibody (1H11-1H7) [HRP]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GRP78/HSPA5
Long Name
75 KD Glucose Regulated Protein
Alternate Names
BIP, HSP70-5, HSPA5
Gene Symbol
HSPA5
Additional GRP78/HSPA5 Products
Product Documents for GRP78/HSPA5 Antibody (1H11-1H7) [HRP]
Product Specific Notices for GRP78/HSPA5 Antibody (1H11-1H7) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...